A pathophysiological approach to metabolic syndrome using factor analysis in an adult Romanian population

Archives of Physiology and Biochemistry

Volumn 112, Issue 3, 2006, Pages 182-188

  Ionescu Tirgoviste, Constantin ^a   Ioacara, Sorin ^a   Guja, Cristian ^a   Sabau, Sorin ^b   Lichiardopol, Radu ^a   Mihai, Andrada ^a   Apetrei, Eduard ^c  

^a Nutrition and Metabolic Diseases 'N Paulescu'   (Romania)

^b TOKAI UNIVERSITY   (Japan)

^c 'CC Iliescu' Institute of Cardiology   (Romania)

Author keywords

Diabetes; Factor analysis; Insulin resistance syndrome; Obesity

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FACTORIAL ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; OBESITY; PATHOPHYSIOLOGY; PRINCIPAL COMPONENT ANALYSIS; ROMANIA; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 33845332423     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.1080/13813450600976374     Document Type: Article

References (43)

1. Alessi M, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. 1997. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 46:860-7.
2. Bertin E, Nguyen P, Guenounou M, Durlach V, Potron G, Leutenegger M. 2000. Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients. Diabetes Metab 26:178-82.
3. Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. 1996. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 45:633-8.
4. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, Shofer JB, Fish BE, Knopp RH, Kahn SE. 2004. Intra-abdominal fat is a major determinant of the National Cholesterol Program Adult Treatment Panel III criteria for the Metabolic syndrome. Diabetes 53:2087-94.
5. Chen W, Srinivasan SR, Elkasabany A, Berenson GS. 1999. Cardiovascular risk factors clustering features of insulin resistance syndrome (syndrome X) in a biracial (black-white) population of children, adolescents and young adults: the Bogalusa Heart Study. Am J Epidemiol 150:667-74.
6. Cheta D. 2006. The Metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes: response to Kahn et al. Diabetes Care 29:176-7.
7. Cnop M, Landchild M, Vidal J, Havel P, Knowles N, Carr D, Wang F. 2002. The current accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 51:1005-15.
8. Choi KM, Lee J, Kim KB, Kim DR, Kim SK, Shin DH, Kim NH, Park IB, Choi DS, Baik SH. 2002. Factor analysis of the metabolic syndrome among elderly Koreans-the South-west Seoul Study. Diabetic Med 20:99-104.
9. Cnop M, Havel P, Utzschneider K, Carr D, Sinha M, Boyko E, Retzlaff B, Knopp R, Brunzell J, Kahn S. 2003. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 46:459-69.
10. Dowse GK, Collins VR, Alberti KG, Zimmet PZ, Tuomilehto J, Chitson P, Gareeboo H. 1993. Insulin and blood pressure levels are not independently related in Mauritians of Asian Indian, Creole or Chinese origin. The Mauritius Non-communicable Disease Study group. J Hypertens 11:297-307.
11. Edwards KL, Austin MA, Newman B, Mayer E, Krauss RM, Selby JV. 1994. Multivariate analysis of the insulin resistance syndrome in women. Arterioscler Thromb 14:1940-5.
12. Edwards KL, Burchfiel CM, Sharp DS, Curb JD, Rodriguez BL, Fujimoto WY, Lacroix AZ, Vitiello MV, Austin MA. 1998. Factors of the insulin resistance syndrome in non-diabetic and diabetic elderly Japanese-American men. Am J Epidemiol 147:441-7.
13. Ferranini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. 1987. Insulin resistance in essential hypertension. New Engl J Med 317:350-7.
14. Ferranini E, Haffner SM, Mitchell BD, Stern MP. 1991. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34:416-22.
15. Gray RS, Fabsitz RR, Cowan LD, Lee ET, Howard BV, Savage PJ. 1998. Risk factor clustering in the insulin resistance syndrome: the Strong Heart Study. Am J Epidemiol 148:869-78.
16. Hanley AJ, Karter AJ, Festa A, D'Agostino R Jr, Wagenknecht LE, Savage P, Tracy RP, Saad MF, Haffner S. 2002. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclrosis Study. Diabetes 51:2642-7.
17. Jorvinen HY. 2003. Insulin resistance in type 2 diabetes. In: Pickup J, Williams, editor, Textbook of diabetes. Oxford: Blackwell Science; pp 22.1-.19.
18. Jee-Young OH, Young SH, Yeon-AH S, Elizabeth BC. 2004. Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care 27:2027-32.
19. Fujimoto W, Abbate S, Kahn S, Hokanson J, Bruzell J. 1994. The visceral adiposity syndrome in Japanese-American men. Obes Res 2:364-71.
20. Kahn R, et al. 2005. The Metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28:2289-2304.
21. Kaiser H. 1960. The application of electronic computers to factor analysis. Educ Psychol Meas 20:141-51.
22. Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, Ito K, Fujii M, Tsuchihashi K, Goto H, Nakatani K, Yano Y. 1998. Serum levels of tumor necrosis factor-alpha are increased in obese patients with nonisulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:859-62.
23. Katsuki A, Sumida Y, Urakawa H, Gabazza E, Murashima S, Maruyama N, Morioka K, Nakatani K, Yano Y, Adachi Y. 2003. Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese, metabolically obese, normal weight subjects with normal glucose tolerance. Diabetes Care 26:2341-4.
24. Kekalainen P, Sarlund H, Pyorala K, Laakso M. 1999. Hyperinsulinemia cluster predicts the development of type 2 diabetes independently of family history of diabetes. Diabetes Care 22:86-92.
25. Kleinbaum D, Kupper L, Muller K. 1988. Applied regression analysis and other multivariate methods. Boston: Kent Publishing Company.
26. Laakso M. 1993. How good a marker is insulin level for insulin resistance? Am J Epidemiol 137:959-65.
27. Lempiainen P, Mykkanen L, Pyorala K, Laakso M, Kuusisto J. 1999. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation 100:123-8.
28. Leyva F, Godsland IF, Ghatei M, Proudler AJ, Aldis S, Walton C, Bloom S, Stevenson JC. 1998. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 18:928-33.
29. Liese AD, Mayer-Davis EJ, Chambless LE, Folsom AR, Sharrett AR, Brancati FL, Heiss G for the Atherosclerosis Risk in Communities Study Investigators. 1999. Elevated fasting insulin predicts incident hypertension: the ARIC study. J Hypertens 17:1169-77.
30. Lonqvist F, Thome A, Nilsell K, Hoffistedt J, Arner P. 1993. A pathogenic role of visceral fat beta 3-adrenoreceptors in obesity. J Clin Invest 95:1109-16.
31. Meigs JB, D'Agostino RB Sr, Wilson PW, Cupples LA, Nathan DM, Singer DE. 1997. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes 46:1594-1600.
32. Miranda P, DeFronzo RA, Califf RM, Guyton JR. 2005. Metabolic syndrome: Definition, pathophysiology and mechanisms. Am Heart J 149:33-45.
33. Modan M, Halkin H. 1991. Hyperinsulinemia or increased sympathetic drive as links for obesity and hypertension. Diabetes Care 14:470-87.
34. Reaven GM. 1988. Role of insulin resistance in human disease. Diabetes 37:1595-607.
35. Reaven G. 1993. Role of insulin resistance in human disease (Syndrome X): an expanded definition. Annu Rev Med 44:121-31.
36. Sakkinen PA, Wahl P, Cushman M, Lewis MR, Tracy RP. 2000. Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 152:897-907.
37. Schmidt MI, Watson RL, Duncan BB, Metcalf P, Brancati FL, Sharrett AR, Davis CE, Heiss G. 1996. Clustering of dyslipidemia, hyperuricemia, diabetes and hypertension and its association with fasting insulin and central and overall obesity in Communities Study Investigators. Metabolism 45:699-706.
38. Shmulewitz D, Auerbach SB, Lehner T, Blundell ML, Winick JD, Youngman LD, Skilling V, Heath SC, Ott J, Stoffel M, Breslow JL, Friedman JM. 2001. Epidemiology and factor analysis of obesity, type II diabetes, hypertension and dyslipidemia (syndrome X) on the Island of Kosrae, Federated States of Micronesia. Hum Hered 51:8-19.
39. Snehalatha C, Sivasankari S, Satyavani K, Vijay V, Ramachandran A. 2000. Insulin resistance alone does not explain the clustering of cardiovascular risk factors in southern India. Diabet Med 17:152-7.
40. Stern SE, Williams K, Ferranini E, DeFronzo RA, Bogardus C, Stern M. 2005. Identification of individuals with insulin resistance using routine clinical measurements. Diabetes 54:333-9.
41. Stevens J. 1996. Applied multivariate statistics for the social sciences. Lawrence Erlbaum: Mahwah, NJ.
42. Wagenknecht L, Langefeld C, Scherzinger A, Norris J, Haffner SM, Saad M, Bergman R. 2003. Insulin sensitivity insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 52:2490-6.
43. Zimmet PZ. 1995. The pathogenesis and prevention of diabetes in adults: genes, autoimmunity and demography. Diabetes Care 18:1050-64.